纳米技术的进步蛋白质分解向金马 (PROTACs):从基础研究向临床应用的过渡
Xupeng Mu1, Chongqiang Mu2, Mengxue Wang2
1Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, 130033, People's Republic of China.
International journal of nanomedicine
|October 13, 2025
概括
化向化马 (PROTACs) 提供了降解疾病蛋白质的新方法. 纳米技术的进步有助于克服PROTAC的交付挑战,用于治疗癌症等困难疾病.
科学领域:
- 生物化学 生物化学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对蛋白质溶解的嵌合体 (PROTACs) 是一种有前途的治疗方法,用于降解与疾病相关的蛋白质,特别是那些对常规药物难以处理的蛋白质.
- 在治疗癌症和神经退行性疾病等耐火性疾病方面,PROTACs具有潜力.
- 然而,临床使用受到诸如高分子量,溶解性差,透性低,效应等问题的阻碍.
研究的目的:
- 审查PROTACs的作用机制和临床意义.
- 探索 PROTAC 交付中的挑战.
- 总结基于纳米技术的战略,以提高PROTAC药物输送,并讨论未来的前景.
主要方法:
- 关于 PROTAC 机制和纳米技术应用的文献综述.
- 分析PROTAC制定和交付中的挑战.
- 对 PROTACs 的纳米输送系统近期进展的综合.
主要成果:
- 纳米技术提供了可行的解决方案,以克服与PROTACs相关的关键交付障碍.
- 最近的进展侧重于提高溶解性,透性,并通过纳米载体减轻效应.
- 纳米技术增强了PROTACs在临床应用中的治疗潜力.
结论:
- 纳米技术显著提高了PROTAC药物递送效率,解决了传统PROTAC的局限性.
- 对纳米输送策略的进一步研究对于在临床环境中推进PROTACs至关重要.
- 这种方法有望开发更有效的治疗复杂和耐火性疾病的方法.
相关概念视频
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


